Alignment Between Trump’s FDA Leader Selection and RFK Jr.’s Health and Transparency Stance

November 26, 2024 TruthUSA

Both RFK Jr. and Marty Makary are vocal critics of COVID-19 mandates and strong advocates for eliminating chemicals and toxins from the American food supply.

Dr. Marty Makary, who is President-elect Donald Trump’s pick to head the Food and Drug Administration (FDA), and Robert F. Kennedy Jr., nominated to lead the Department of Health and Human Services (HHS), share a common stance against COVID-19 mandates, supporting the removal of harmful substances from the nation’s food sources, and calling for increased transparency in the healthcare industry.

If confirmed by the Senate in January 2025, Kennedy will be Makary’s superior as the FDA operates under the umbrella of HHS.

Both Makary and Kennedy have raised concerns about the use of pesticides in food, the indiscriminate prescription of medications, and the undue influence of insurance and pharmaceutical companies on healthcare policies, all topics that Kennedy has been addressing for years.

Kennedy has pledged to reform the FDA, National Institutes of Health (NIH), and the Centers for Disease Control and Prevention, which he believes are overly influenced by corporate interests.

On receiving his nomination, Kennedy extended his congratulations to Makary.

“I am eager to collaborate with you to uphold the FDA’s legacy of relying on superior, evidence-based science, ending corporate dominance, and promoting the health of America,” he stated in a social media post on Nov. 23.

After the announcement of Makary as the FDA nominee, Trump expressed his dissatisfaction with the agency’s loss of trust among Americans and its deviation from its primary regulatory goals in a post on Truth Social on Nov. 22.

Trump emphasized the need for Makary to steer the FDA back on track, specifically in addressing harmful chemicals in food supplies and the inappropriate administration of drugs and biologics, to combat the Chronic Disease Epidemic.

Makary, an accomplished surgeon and professor from Johns Hopkins, aligns with Kennedy on various health issues, including the need for reforms in federal health agencies and the criticism of the US government’s communication on chronic diseases through the food pyramid.

Makary and Kennedy participated in a debate regarding health and nutrition hosted by Sen. Ron Johnson (R-Wis.). Makary raised concerns about the inadequate attention to chronic diseases by federal health agencies and the negative impact of misinformation spread by the government through the food pyramid.

Makary highlighted the adverse effects of poisoning the food supply and the prevailing profit-oriented mindset within the healthcare system.

During the health roundtable, Makary echoed Kennedy’s views on healthcare, emphasizing the necessity to address the root causes of chronic diseases rather than passively treating symptoms.

Makary voiced concerns about the US healthcare system’s failure to address chronic diseases effectively and urged a shift in focus towards preventive care.

He criticized the prevailing ethos of symptom management over curing diseases and highlighted the significance of addressing root causes to improve overall health outcomes.

Former President Donald Trump shakes hands with Robert F. Kennedy Jr. at a presidential campaign rally at the Desert Diamond Arena in Glendale, Ariz., on Aug. 23, 2024. (Evan Vucci/AP Photo) — Former President Donald Trump shakes hands with Robert F. Kennedy Jr. at a presidential campaign rally at the Desert Diamond Arena in Glendale, Ariz., on Aug. 23, 2024. Evan Vucci/AP Photo

Upon suspending his independent presidential campaign in Arizona on Aug. 23, Kennedy endorsed Trump while outlining his vision for transforming the healthcare system.

Kennedy proposed three key initiatives to promote health in the nation, including tackling corruption within health agencies, altering the incentives in the healthcare system, and motivating Americans to prioritize their health.

Kennedy emphasized the urgent need for restructuring the FDA, CDC, and Department of Agriculture to refocus on health and public safety rather than corporate interests.

He pledged to replace agency leaders with individuals committed to healing and public health, intending to reverse the agencies’ current alignment with corporate priorities, as stated in an interview with NBC News.

Kennedy also advocated for a reduction in the FDA’s size, particularly targeting departments like the nutrition division that have demonstrated inadequacies in safeguarding public health.

Makary’s initial stance on COVID-19 measures differed from Kennedy’s, supporting universal masking in May 2020 in a column for The New York Times.

However, Makary later emerged as a vocal opponent of pandemic responses, expressing reservations about mandatory booster shots and advocating for recognizing the value of natural immunity.

He cited numerous studies supporting the equivalence or superiority of natural immunity compared to vaccine-induced immunity, highlighting the detrimental effects of overlooking natural immunity on public health.

Makary, a noted public policy researcher and bestselling author, emphasized the importance of transparency and accountability in healthcare, illustrating the need to address predatory billing practices and price gouging in his publications.

In his recent book, “Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health,” Makary underscored the hazards of “groupthink” in the medical field and called for more objectivity and humility in shaping health recommendations.

During an interview in September, Makary stressed the importance of basing medical decisions on sound scientific evidence and avoiding the pitfalls of relying on subjective opinions.

He urged for a culture of transparency among medical professionals, advocating for the immediate disclosure of research outcomes, no matter the outcome.

Makary highlighted the necessity for civil discourse and the elimination of cancel culture in medicine, citing examples of biased reporting in the medical field.

Trump nominated a total of three prominent figures to key roles within HHS, with Makary, Dr. Dave Weldon, and Dr. Mehmet Oz receiving nominations.

Amid these nominations, Kennedy was selected to lead HHS, signaling a potential wave of reforms within federal health agencies.

These appointments mark a significant shift towards prioritizing public health and transparency in American healthcare, setting the stage for substantial changes in government healthcare policies.

Source link